News
AZTA
49.91
+23.30%
9.43
Azenta price target raised to $52 from $44 at Jefferies
TipRanks · 2h ago
Wednesday Sector Leaders: Semiconductors, Computer Peripherals
NASDAQ · 3h ago
Azenta Up Over 17%, On Pace for Largest Percent Increase Since August 2023 -- Data Talk
Dow Jones · 4h ago
Insider Buying Signals: 3 Healthcare Stocks to Watch
Investorplace · 4h ago
Is Azenta (AZTA) Reasonable After Its Gene Synthesis Expansion?
Simply Wall St · 8h ago
Azenta shares skyrocket, what you need to know
Barchart · 10h ago
Azenta Shares Gain on 4Q Revenue, Earnings Beat
Dow Jones · 21h ago
Azenta sees Q1 organic revenue growth 3%-4% vs. last year
TipRanks · 22h ago
*Azenta: Total Organic Rev Growth Is Expected to Range Approximately Between 3%-4% Relative to 1Q FY26 >AZTA
Dow Jones · 22h ago
Azenta Sees FY2027 Sales $648.000M-$660.000M vs $639.051M Est
Benzinga · 22h ago
Here are the major earnings after the close Tuesday
Seeking Alpha · 1d ago
Weekly Report: what happened at AZTA last week (1102-1106)?
Weekly Report · 2d ago
Azenta earnings: what to look for from AZTA
Barchart · 2d ago
Azenta (AZTA) Expands GENEWIZ With New Deals, Is The Recovery Already Priced In?
Simply Wall St · 2d ago
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
PR Newswire · 3d ago
Did DNA Licensing Just Shift Azenta (AZTA) Stock Narrative?
Simply Wall St · 4d ago
Azenta: A Sample Custody Annuity Priced Like A Broken Equipment Vendor
Seeking Alpha · 11/03 17:30
Weekly Report: what happened at AZTA last week (1026-1030)?
Weekly Report · 11/02 10:20
Azenta (AZTA) And The Valuation Question As GENEWIZ Expands
Simply Wall St · 11/01 22:29
Gene Technology Deals Might Change The Case For Azenta Stock
Simply Wall St · 10/31 14:39
More
Webull provides a variety of real-time AZTA stock news. You can receive the latest news about Azenta Inc through multiple platforms. This information may help you make smarter investment decisions.
About AZTA
Azenta, Inc. provides life sciences solutions. The Company provides biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It delivers and supports these products and services through its industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.